Cervical spine involvement in rheumatoid arthritis over time: results from a meta-analysis by unknown
Zhang and Pope Arthritis Research & Therapy  (2015) 17:148 
DOI 10.1186/s13075-015-0643-0RESEARCH ARTICLE Open AccessCervical spine involvement in rheumatoid arthritis
over time: results from a meta-analysis
Tony Zhang and Janet Pope*Abstract
Introduction: Complications in rheumatoid arthritis (RA) seem less common than they were years ago. The
prevalence and progression of anterior atlantoaxial subluxations (aAASs), vertical subluxations (VSs), subaxial
subluxations (SASs), and associated cervical myelopathy in RA over the past 50 years were determined.
Methods: A literature search was performed by using Medline-OVID/EMBASE, PubMed, and Scopus (from 1960 to
June 21, 2014). Prevalence studies were included if the sample size was at least 100 or the prevalence/progression
of cervical subluxations was reported. Study quality was assessed by using the Strengthening the Reporting of
Observational Studies in Epidemiology (STROBE) checklist. Prevalence of cervical subluxations was calculated for
each study. Student’s t test and meta-regression were used to evaluate for significance.
Results: In total, 12,249 citations were identified and 59 studies were included. The prevalence of aAAS decreased
from 36% (95% confidence interval (CI) 30% to 42%) before the 1980s to 24% (95% CI 13% to 36%) in the 2000s
(P = 0.04). The overall prevalence rates were 11% (95% CI 10% to 19%) for VS, 13% (95% CI 12% to 20%) for SAS,
and 5% (95% CI 3% to 9%) for cervical myelopathy, and there were no significant temporal changes. Rates of
progression of aAAS, VS, and SAS were 4, 6, and 3 lesions per 100 patients per year, respectively. The incidence of
new or progressive cervical myelopathy was 2 cases per 100 patients with known cervical subluxations per year.
Conclusions: Since the 1960s, only aAAS has decreased dramatically. It is still more than twice as common as VS or
SAS. No temporal changes in the development of cervical myelopathy in affected patients with RA were noted. The
progression rates of cervical subluxations and myelopathy were unchanged over time.Introduction
Rheumatoid arthritis (RA) is a chronic systemic inflam-
matory disease that primarily affects the joints. Although
inflammatory arthritis of the small joints in the hands
and feet is a common clinical manifestation, the cervical
spine can also be affected. In fact, cases surfaced as early
as 1890, when A. E. Garrod reported 178 patients with
cervical spine involvement in a series of 500 patients
with RA [1]. Cervical spine involvement can take many
forms. Reported findings include vertebral endplate ero-
sions, spinous process erosions, and apophyseal joint
changes, such as osteoporosis, blurring, and fusion [2,3].
The most characteristic lesions are subluxations [4,5].
The atlas-axis—cervical vertebrae 1 and 2 (C1 and
C2)—articulation is one of the prime disease targets. The* Correspondence: janet.pope@sjhc.london.on.ca
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stated.erosive pannus formation at this joint often leads to bony
destruction and laxity in the surrounding ligamentous
complex, especially the transverse ligament that aligns that
atlas and axis. The subsequent loss of anchoring structures
results in atlantoaxial subluxation (AAS) [6]. The sublux-
ation can be anterior, posterior, lateral, and rotatory. The
anterior atlantoaxial subluxation (aAAS) is the most com-
mon subtype; the reported prevalence ranges from 10% to
55% [2,3,7-9]. This wide range may be related to the vari-
ation in the radiographic definition of aAAS. Separation of
the anterior odontoid peg (dens) from the anterior ring of
atlas (altanto-dental interval) of greater than 2.5 mm to 5
mm has been considered pathological [2,10-12]. Posterior
AASs are less frequent and often due to fracture of the
dens [13]. Lateral subluxations are considered when lateral
masses of C1 are displaced laterally more than 2 mm in
comparison with C2. They can lead to head tilt and rota-
tional deformities [5].tral. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly cited. The Creative Commons Public Domain Dedication
ain/zero/1.0/) applies to the data made available in this article, unless otherwise
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of the axis (VS), also known as altantoaxial impaction, cra-
nial settling, superior migration of the odontoid, or psue-
dobasilar invagination. It is secondary to the destruction
of occipitoatlantal and atlantoaxial joints and surrounding
soft tissues [5]. Not surprisingly, many studies have shown
that AAS and the destruction of C1-C2 articulation tend
to predate the development of VS [14-16].
Lastly, subaxial subluxation (SAS) is associated with
the damage to the facet joints, interspinous ligaments,
and intervertebral discs. It can happen at one or multiple
levels, leading to a step-ladder deformity and kyphosis
[5]. SAS is defined by a misalignment of more than 3
mm between the anterior bodies of two consecutive ver-
tebrae, although a threshold of 1 mm has also been
found in studies [4,17]. Neck subluxations can develop
over the course of the disease process, and there is an
increased risk of developing neurological complications.
Tinnitus, vertigo, and visual changes associated with ver-
tebrobasilar insufficiency or brainstem compression can
arise [6]. Patients may experience myelopathic symp-
toms. Once severe neurological complications develop,
the prognosis can be grave; 1-year mortality can be as
high as 50% if the condition is left untreated [18].
It appears that RA complications such as rheumatoid
nodules, corneal melts, vasculitis, and C-spine subluxa-
tions are less frequent than they were years ago. Given the
improved RA management over the past 50 years, our ob-
jectives were to quantify and evaluate temporal changes in
the prevalence and progression of various RA-related cer-
vical subluxations and cervical myelopathy.
Methods
Study selection
A comprehensive literature search was performed by
using the Medline-OVID/EMBASE, PubMed, and Sco-
pus databases from 1960 to June 21, 2014. We looked
for studies of cervical subluxations in patients with RA














14. SAS15.or/2 to 14
16.1 and 15.
Identified titles/abstracts were reviewed, and full reports
were obtained if appropriate. Studies were considered if
they provided data on the prevalence or progression of
any cervical subluxations in patients with RA. Studies
reporting prevalence required a sample size of at least 100
patients with RA. Another inclusion criterion was publica-
tion in English. Case reports, case series of fewer than 100
patients for the estimate of prevalence, and review articles
were excluded. Cervical spine involvement of RA patients
who were followed over time was included for the rate of
progression analyses. Additional articles were retrieved by
hand by searching relevant references.
Data collection
Information from the studies was extracted by one re-
viewer (TZ) and ambiguities were resolved with the
other reviewer (JP). A standard data extraction form was
used to extract the following information:
Prevalence studies: year of publication, author, location
of study, study design, patient population, sample size,
number of females, mean age, mean disease duration,
and proportion with any cervical changes, aAAS, poster-
ior AAS, lateral AAS, rotatory AAS, VAS, SAS, cervical
myelopathy, brainstem compression/vertebral artery in-
volvement, and their respective definitions.
Progression studies: year of publication, author, loca-
tion of study, study design, patient population, sample
size, number of females, mean age, mean disease dur-
ation, years of follow-up, baseline, and rate of progres-
sion of aAAS, VS, SAS, cervical myelopathy and number
of progressive/new cervical myelopathies. If studies in-
cluded patients with RA and other rheumatic diseases,
only data pertaining to the RA cohort were extracted.
Quality assessment
Each study was assessed by using the Strengthening
the Reporting of Observational Studies in Epidemiology
(STROBE) checklist [19], which is a 22-item checklist re-
lating to the title and abstract of the article (item 1), back-
ground and objectives (items 2 and 3), methods (items 4
to 12), results (items 13 to 17), discussion (items 18 to 21),
and funding (item 22). The purpose of STROBE is not to
give a quality score but to ensure clear presentation of
reporting.
Statistical analysis
Proportions were pooled with a random effects model
[20]. Forest plots were created to estimate prevalence
with a 95% confidence interval (CI). The I2 statistic was
used to quantify the magnitude of heterogeneity (mild,
0% to 30%; moderate, 31% to 50%; high, more than
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study variance, and P value was for Cochrane’s Q, the
classic measure of heterogeneity. Owing to significant
heterogeneity, Forest plots and pooled estimates were
not reported. Student’s t test was performed to evaluate
regional differences in aAAS. Meta-regression through a
random effects model was also used to explore the
study-level associations between the prevalence of vari-
ous C-spine complications and year of publication. A P
value of less than 0.05 was considered statistically signifi-




The literature search identified 12,249 citations with 412
duplicates. Titles or abstracts (if available) were screened
for eligibility, yielding 126 citations for full text review.
Twelve studies were case reports. Twenty-nine studies
were editorials or reviews. Eleven studies did not report
on the rate or progression of cervical complications.
Eleven studies examined patients with severe neck com-
plaints or suspected/known cervical instabilities. Six
excluded studies examined the prevalence of cervical in-
stabilities in RA but had a sample size of less than 100.
Two articles were identified by hand-searching key refer-
ences. In total, 67 articles were excluded, leaving 59
studies to be included in our meta-analysis (Figure 1).
Description of the included studies and participants
Fifty studies reported on the prevalence of cervical in-
stabilities. Three studies were published in the 1960s
with 533 participants (4% of pooled study population),
nine studies in the 1970s with 2,798 participants
(23%), nine studies in the 1980s with 1,449 parti-
cipants (12%), nine studies in the 1990s with 1,653
participants (14%), 13 studies in the 2000s with 3,777
participants (31%), and seven studies in the 2010s
with 2,012 participants (16%) [2-4,7-12,15,17,21-59].
The total number of enrolled patients was 12,222. Major
world regions were represented. Six studies were from the
United States, including 855 participants (7% of pooled
study population) [3,15,17,21,33,35]. Twenty-six studies
were from Europe with a total of 7,315 participants (60%)
[2,4,7,10,22-25,27-31,34,37,38,40,43-46,49-52,59]. Six-
teen studies were conducted in Asia, totaling 3,662 par-
ticipants (30%) [8,9,12,26,32,39,41,42,47,48,53-58]. An
additional study compared a Malaysian cohort with a
British cohort with a total of 140 patients [36]. One
study was from Africa and included 250 people (2%)
[11]. The average female representation was 75%. The
mean age at the time of outcome assessment was 58
years old (range of 33 to 69 years), and the mean dis-
ease duration was 12 years (range of 2 to 30 years).Twenty studies were included for analyzing the progres-
sion of cervical instabilities. Data were obtained from 12 of
the studies described above as well as nine additional stud-
ies [7,8,14-16,22,23,25,29,32,42,55,56,60-66]. The number
of enrolled participants was 2,157, and the average follow-
up was 6 years (range of 3 to 10 years). Eighty percent of
the participants were female. The mean age and disease
duration at the time of final assessment were 60 years
(range of 50 to 67 years) and 15 years (range of 7 to 30
years), respectively.
Across all studies, the median number of items ful-
filled on the STROBE checklist was 16 (range of 11 to
19) and reporting was improved in more recent studies.
Characteristics of the included studies are shown in
Tables 1 and 2.
Prevalence of any rheumatoid arthritis-related changes,
cervical subluxations, and cervical myelopathy
Twelve studies reported the prevalence of any RA-related
cervical changes, not limited to subluxations. Out of 3,559
patients, 1,597 (45%) were found to have one or more of
those radiographic changes. There were no significant
changes over time of publication (P = 0.71).
AAS was the most common subluxation found in our
study. Twenty-seven percent (2,737 patients) had aAAS.
Lateral AAS was reported in 68 patients (0.7%). Poster-
ior and rotatory AASs were found in 21 (0.2%) and 10
(0.1%), respectively. In comparisons among different
world regions, the prevalences of aAAS were 25%, 27%,
and 31% for Europe, North America, and Asia, respect-
ively (P = 0.13). The prevalences of aAAS were 36% in
the 1970s and earlier (95% CI 30% to 42%), 36% in the
1980s (95% CI 23% to 42%), 32% in the 1990s (95% CI
20% to 44%), and 24% in the 2000s (95% CI 13% to 36%)
(P = 0.04). VS and SAS had comparable prevalence rates.
VSs were reported in 831 of 7,675 patients with RA with
a prevalence of 11% (95% CI 10% to 19%); SAS occurred
in 838 of 6,672 patients with RA (13%; 95% CI 12% to
20%). No significant temporal changes were noted for ei-
ther VS or SAS (P = 0.17 and P = 0.49, respectively).
Twenty-three studies with 5,106 patients with RA re-
ported on cervical myelopathy. Two hundred seventy-one
patients (prevalence of 5%) had observed neurological def-
icits corresponding to Ranawat Cervical Myelopathy Clas-
sification II and above (95% CI 3% to 9%) [67]. We did not
observe a significant change over time (P = 0.22). In terms
of serious neurological complications, nine patients (0.2%)
were observed to develop paraplegia. Ten additional pa-
tients (0.2%) had symptoms of possible brainstem involve-
ment, including nausea, vertigo, or drop attacks.
Progression of cervical subluxations and cervical myelopathy
Sixteen studies reported on the progression of 945 aAAS
lesions. After 10,046 person-years, 219 of the existing
12249 citations were identified:
- 1853 articles from MEDLINE/EMBASE
- 6724 articles from PubMed
- 3672 articles from Scopus
12123 citations were excluded:
- 412 were duplicates
- 23 were not published in English
- 11688 other studies did not meet inclusion criteria
126 articles were selected for full text review:
- 2 articles were identified by  hand searching key references
- 69 articles were excluded:
12 articles were case reports
29 articles were editorials or reviews
11 articles did not report on rate/progression of cervical complications
11 articles examined patients with severe neck complaints, known/suspected cervical instabilities
6 prevalence studies had sample size less than 100
59 articles were included for meta-analysis
A
B
Figure 1 (See legend on next page.)
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Figure 1 (A) Search strategy for articles and (B) Funnel plots to determine if there was publication bias. Funnel plot 1: Graph of sample size of individual
study (x-axis) and its respective prevalence of anterior atlanto-axial subluxations (y-axis). Funnel plot 2: Graph of sample size of individual study (x-axis) and
its respective prevalence of rheumatoid arthritis (RA)-related cervical changes (y-axis). Funnel plot 3: Graph of sample size of individual study
(x-axis) and its respective prevalence of vertical atlanto-axial subluxations (y-axis). Funnel plot 4: Graph of sample size of individual study (x-axis)
and its respective prevalence of subaxial subluxations (y-axis). Funnel plot 5: Graph of sample size of individual study (x-axis) and its respective
prevalence of cervical myelopathy (y-axis).
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on radiography. Therefore, on average, 4 out of 100
existing aAAS lesions progressed per year. As for VS,
148 of 407 known lesions had radiographic progression,
following 8,468 person-years. This corresponded to a
progression rate of 6 per 100 lesions per year. Lastly,
only 5 studies reported on SAS progression. A total of
46 out of 208 existing lesions progressed during the
4,781 person-years of follow-up. Therefore, the rate of
SAS progression was 3 lesions per 100 existing lesions
per year. The rate of progression for these subluxations
was not found to be significantly different over time
(aAAS, P = 0.99; VS, P = 0.49). Owing to the small num-
ber of studies, the rate of SAS progression over time was
not analyzed.
Cervical myelopathy was assessed in 1,310 patients
with RA with 9,131 person-years of follow-up. A total of
772 people had AAS, VS, SAS, or a combination of sub-
luxations. Seventy-nine had new or progressive cervical
myelopathy at the end of follow-up. We thus calculated
a rate of 1.5 new/progressive cervical myelopathies per
100 patients with known cervical subluxations per year.
Over time, the rates were 0.8, 2.1, 1.3, and 2.4 for the
1970s, 1980s, 1990s, and 2000s, respectively (P = 0.05).
Discussion
Cervical spine involvement in RA has long been recog-
nized. Varying degrees of prevalence have been reported
as reflected in our literature search. This can be ex-
plained by numerous factors, such as differences in sam-
ple size, disease duration, follow-up period, medications
used, and radiological criteria. There may also be report-
ing bias in which once something is well described,
fewer publications follow over time. To the best of our
knowledge, this is the first study to systematically evalu-
ate the prevalence and progression of cervical subluxa-
tions and cervical myelopathy in patients with RA.
The earliest form of cervical instability in patients with
RA has been shown to be a reducible AAS [62]. AAS is the
most common cervical subluxation in RA. (AAS is twice as
common as VS or SAS, and other types are very uncom-
mon.) No regional differences in aAAS were found between
Asia, Europe, and North America. However, a significant
temporal reduction in the prevalence of aAAS exists, de-
creasing by one third from the 1960s and 1970s to 2000.
The could reflect the changes in RA management (earlierintroduction of DMARDs with higher doses and more
combinations), or changing epidemiology of RA with fewer
complications compared to years ago, and or reporting bias
where the complications that are well described are less
likely to be published over time so the contemporary rates
may not be fully reported (publication bias).
The effects of DMARDs were addressed specifically in a
number of studies. For example, Neva and colleagues re-
cruited 198 early RA patients who were randomly assigned to
either combination DMARDs (sulfasalazine, methotrexate,
and hydroxychloroquine) or a single DMARD with or without
prednisone [43]. After 2 years of follow-up, aAAS was found
in 3% of the patients. None of the patients who were receiving
combination therapies had aAAS. Lending further support to
the role of DMARDs in preventing cervical involvement, bio-
logical agents were examined in two studies. A cohort of 38
early RA patients who received more than 2 years of continu-
ous infliximab treatment in addition to methotrexate and
prednisone was followed for 4 years [64]. Only one of the pa-
tients developed de novo AAS. In another study, a group of 91
patients who were on infliximab, etanercept, or tocilizumab
was followed for 4 years [65] and three developed AAS.
Whereas the prevalence of aAAS seemed to be on the
decline with the introduction of DMARDs, that of SAS
and VS did not. This could be related to the natural pro-
gression of cervical subluxations. Our results demon-
strated that, once formed, 4 out of 100 aAAS lesions
would have an increase in atlanto-dental interval per year.
After a certain point, AAS can have the appearance of
stabilization or even improvement in the atlanto-dental
interval on x-ray, signaling the beginning of VS. For ex-
ample, Rana followed 41 AAS patients over a period of 10
years. Ten percent of the patients had less AAS secondary
to new development of VS and upward translocation of
odontoid process [16]. Smith and colleagues reported a
similar phenomenon in 13% of their cases [23]. SAS gener-
ally develops at a later stage and is often seen after devel-
opment of VS [68]. The lack of temporal reduction in the
prevalence of VS and SAS may therefore be because
DMARDs are less effective in preventing progression of
existing lesions or due to a very low prevalence resulting
in insufficient power to detect a change. When biologics
were used, if there was C-spine subluxation, 79% to 80%
progressed further [64,65]. We suspect that, eventually,
the prevalence of VS and SAS will decrease as fewer de
novo AASs are being formed.













1963 Bland [21] USA 11 100 65 (65%) 56 14.4
1966 Conlon [2] New Zealand 14 333 230 (69%) 52.7 N/A
1969 Park [3] USA 12 100 N/A N/A 10
1971 Meikle [4] Scotland 15 118 83 (70%) 57.6 12.9
1971 Isdale [22] New Zealand 13 171 N/A N/A 12.1
1971 Stevens [10] UK 16 100 73 (73%) 54.2 11.3
1972 Smith [23] UK 13 962 588 (61%) 51.3 7.4
1975 Henderson [24] UK 15 476 N/A N/A N/A
1976 Shaw [25] UK 11 100 73 (73%) 54.2 N/A
1978 Higashiyama [26] Japan 12 100 91 (91%) N/A N/A
1978 Chevrot [27] France 14 577 N/A N/A N/A
1979 Jensen [28] Denmark 14 194 N/A N/A N/A
1981 Winfield [29] UK 14 100 56 (56%) 54.8 7.7
1981 Pellici [15] USA 14 106 88 (83%) 62.6 30.1
1982 Halla [17] USA 15 126 86 (68%) 57.6 11.1 s
1983 Winfield [7] UK 17 100 57 (57%) 57.1 10.0
1984 Haaland [30] Norway 16 104 77 (74%) N/A 15.3
1985 Redlund-Johnell [31] Sweden 16 450 351 (78%) 63.5 N/A
1987 Morizono [32] Japan 14 100 92 (92%) 57.1 12.8
1989 Floyd [11] South Africa 15 250 187 (75%) 52.8 N/A
1989 Collins [33] USA 14 113 59 (52%) 55 15
1990 Kauppi [34] Finland 17 164 136 (83%) 57.3 19.3
1990 Halla [35] USA 16 310 198 (64%) 68.8 10.2
1993 Veerapen [36] Malaysia Britain 18 140 140 (100%) 46.5 10.1
1994 Stiskal [37] Austria 18 136 110 (81%) 57 13
1994 Montemerani [38] Italy 17 183 147 (80%) 33.4 12.3
1996 Aggarwal [39] India 16 100 73 (73%) N/A 5
1998 Fujiwara [8] Japan 17 173 146 (84%) 55.6 12.5
1998 Schramm [40] Germany 14 150 134 (89%) 56.5 12.3
1999 Yoshida [41] Japan 16 297 251 (85%) 57.0 13.0
2000 Fujiwara [42] Japan 15 161 134 (83%) 59.5 16.5
2000 Neva [43] Finland 16 176 111 (63%) 48.5 2.5
2001 Riise [44] Norway 16 241 156 (65%) 61.9 5.4
2003 Carmona [45] Spain 18 788 562 (71%) 61.0 10.0
2003 Neva [46] Finland 17 103 70 (68%) 56.0 9.8
2004 Mitsuka [47] Japan 15 174 156 (90%) 60.9 19.1
2004 Pisitkun [48] Thailand 17 134 124 (93%) 48.9 5.0
2004 Naranjo [49] Spain 16 736 530 (72%) 61.4 9.0
2005 Zikou [50] Greece 17 165 143 (87%) 59.6 12.3
2005 Vesela [51] Czech Republic 15 400 N/A N/A N/A
2006 Neva [52] Finland 18 154 117 (76%) 62.0 16.0
2008 Kim [53] Korea 18 405 365 (90%) 56.0 10.8
2009 Al-Ghamdi [54] Saudi Arabia 18 140 105 (75%) 47.2 6.9
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Table 1 Characteristics of 50 studies reporting prevalence of cervical subluxations (Continued)
2010 Imagama [12] Japan 17 100 84 (84%) 61.0 13.0
2010 Ahn [55] Korea 16 1,120 N/A N/A N/A
2011 Yurube [56] Japan 18 267 220 (82%) 66.9 N/A
2012 Hirano [9] Japan 18 101 N/A 65.6 19.2
2012 Yurube [57] Japan 19 140 107 (76%) 68.3 18.5
2012 Eser [58] Japan 17 150 126 (84%) 53.2 12.3
2013 Blom [59] The Netherlands 16 134 90 (67%) 60.6 9.5
N/A, not applicable; STROBE, Strengthening the Reporting of Observational Studies in Epidemiology.
Zhang and Pope Arthritis Research & Therapy  (2015) 17:148 Page 7 of 9Although cervical subluxations are common as illus-
trated above, their clinical presentation is often asymp-
tomatic or associated with neck pain. Neurological
complications are less frequent and tend to occur later in
the disease course [69]. In our study, we reported a 5%
prevalence rate for observed neurological deficits in pa-
tients with RA on the basis of the Ranawat grading system.
Class I patients have pain but no neural deficits and there-
fore were not counted for our study. Class II patients have
subjective weakness with hyperreflexia and dyssthesias.
Class III patients have objective weakness and long tract
signs. Class IIIA patients are ambulatory whereas IIIB
patients are non-ambulatory [67]. Serious complications
were rare, however. Paraplegia was reported in 0.2% of pa-








1971 Isdale [22] New Zealand 13 171
1972 Smith [23] UK 13 84
1974 Matthews [14] UK 11 54
1976 Shaw [25] UK 11 75
1981 Winfield [29] UK 14 100
1981 Pellici [15] USA 14 106
1982 Weissman [60] USA 16 109
1983 Winfield [7] UK 17 100
1987 Morizono [32] Japan 14 27
1989 Rana [16] USA 15 41
1995 Oda [61] Japan 14 49
1997 Paimela [62] Finland 16 67
1997 Fujiwara [63] Japan 13 79
1998 Fujiwara [8] Japan 17 173
2000 Fujiwara [42] Japan 15 161
2010 Ahn [55] Korea 16 137
2011 Yurube [56] Japan 18 267
2012 Kaito [64] Japan 18 38
2013 Kaito [65] Japan 18 91
2014 Yurube [66] Japan 19 228
N/A, not applicable; STROBE, Strengthening the Reporting of Observational Studiesinvolvement, such as vertigo and drop attacks, were found
in another 0.2%. We did not observe a decrease in the
already-rare prevalence or progression of cervical myelop-
athy over time.
This study has limitations. Non-English studies were ex-
cluded. Although some asymmetries existed in our funnel
plots, we do not believe that this represented major publi-
cation bias. Our data had significant heterogeneity. Age,
disease duration, RA activity and severity, and treatments
such as DMARDs and corticosteroids were not assessed.
Estimates were generated at a population level. Inclusion
criteria for some case series were not described in detail,
and so the generalizability of the findings is unknown. We
did not present the overall meta-analysis results, because









N/A N/A 12.1 6.0
64 (76%) N/A N/A 7.8
N/A N/A N/A 5.0
N/A N/A N/A 6.0
56 (56%) 54.8 7.7 7.2
88 (83%) 62.6 30.1 6.1
90 (83%) 63.1 20.9 4.9
57 (57%) 57.1 10.0 9.5
27 (100%) 56.3 22.4 5.3
N/A N/A N/A 10
43 (88%) 53.8 10.0 7.8
56 (84%) 49.7 7.0 6.5
66 (84%) N/A N/A 6.4
146 (84%) 55.6 12.5 5.9
134 (83%) 59.5 16.5 10.2
123 (90%) 55.1 7.4 3.0
220 (82%) 66.9 N/A 6.0
33 (87%) 61.0 14.2 4.4
74 (81%) 60.7 14.9 3.9
183 (80%) 67.0 19.2 6.0
in Epidemiology.
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trial-level differences contributing to the heterogeneity
(such as year of publication) by using meta-regression,
which quantifies the effect of a study characteristic (publi-
cation year) on the overall effect of heterogeneity in the
rate of C-spine subluxations. The review may be limited
by variation in study quality, especially with the earlier
publications having lower STROBE scores (as is often seen
when comparing older with more recent studies due to
different standards). Lastly, another factor to consider
when interpreting the study is that cervical complications
tend to develop over time. Even though our review in-
cluded data from recent studies, the long-term effects of
modern DMARDs (type and how we use them) on devel-
opment and progression of cervical instabilities have yet to
be adequately studied, and it could take years before differ-
ences in complications can be identified as C-spine com-
plications could take years to develop or be prevented.
Conclusions
Patients with RA are still at risk for cervical spine in-
volvement. Over the past 50 years, we have found a sig-
nificant decrease in the prevalence of aAAS, possibly
due to improved disease control with modern DMARDs
or changing epidemiology of RA. However, aAAS re-
mains the most common lesion with a prevalence of
27%, more than twice as common as SAS or VS. The
prevalence of cervical myelopathy did not change dra-
matically and remains at 5% among patients with RA.
The rate of progression of cervical subluxations and
myelopathy did not seem to be affected significantly by
DMARDs.
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